Home » From the Director’s Desk

From the Director’s Desk

Welcome To Axigen

With a devotion to reduce the burden of disease, we entered into the healthcare space in May 2018. In a short span of time, Axigen Healthcare has become the fastest growing pharmaceutical company, reaching out to over 10000+ doctors and 30000+ chemists.
A name that has become synonymous with quality, innovation and new product development, I would like to thank all my stakeholder for the opportunity and the trust that you have provided throughout our journey.

Indian Pharmaceutical market is at an exciting stage. The market is going to open up significantly in coming years because of increase in penetration of modern medicines, increased government investment in healthcare in the next three years. Also, the industry has been witnessing regulatory challenges and the impact of national and global economic situations. As an organization, we see all the good reasons for these changes; the changes would not only help the industry to be more responsible but will help us stay focused at improving lives of patients through our patient centric approach. The strong sales and distribution network, processes and system, logistic channels, partnership with other innovators, efficient field force and the brands will help us to take the benefit of modern medicine to larger population of our country and leverage the Indian opportunity. We continue to invest in market and our people in coming years. With an increased thrust on science & training and highest ethical standards, we are determined to accelerate our performance and take our products to more doctors & patients.

The leadership role comes with the sense of responsibility. Axigen, is built on core values that center our work and help focus what we do and the decision we make. We have a culture of high performance and sustain this culture through our best-in-class rewards & recognition program and a great place to work for our people. Our key focus areas lie in the prescription drugs that have wide-ranging applications across fields like Gynaecology, Infertility Management, Science-based Nutritional Health, Dermatology, Gastroenterology, Pain Management and Acute care.

We have established world-class manufacturing partners by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliances. Plants are WHO, cGMP, GLP, ISO 9001, ISO 22000, HACCP, PPB Kenya, NDA Uganda certified. Manufacturing facilities have at multiple locations in India like Haryana, Dehradun, Ahmedabad and Haridwar. We are planning gradually building a meaningful presence in the Russia & CIS and US market, with select product portfolio, which include complex technology products to get the competitive advantage in the market place. We expect US market to be our key growth driver in the coming years. It also has its marketing plan in emerging markets of African Countries: Zimbabwe, Kenya, Uganda, Nigeria and French West Africa; Asian Countries: Sri Lanka, Vietnam, Myanmar, Philippines, Malaysia, Nepal and Bangladesh; MENA (Middle East North Africa).

Doctors are continuing to remain our driving force, while we strive to support doctors in the mission to build a healthy India.

Axigen’s 4 domestic marketing divisions cater to different therapeutic segments including Gynaecology, Infertility Management, Science-based Nutritional Health, Dermatology, Gastroenterology, Pain .Management and Acute care.Axigen Healthcare has become the fastest growing pharmaceutical company, reaching out to over 10000+ doctors and 30000+ chemists. A name that has become synonymous with quality, innovation and new product developmentAxigen Healthcare has a strong domestic presence in India with established world-class manufacturing partners by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliances.Axigen Healthcare also planning a strong international presence spread across 40 countries with operations in regulated and emerging markets and Russia & CIS and United States of America.Management and Acute care.Axigen Healthcare has become the fastest growing pharmaceutical company, reaching out to over 10000+ doctors and 30000+ chemists. A name that has become synonymous with quality, innovation and new product development.Axigen Healthcare has a strong domestic presence in India with established world-class manufacturing partners by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliancesAxigen Healthcare also planning a strong international presence spread across 40 countries with operations in regulated and emerging markets and Russia & CIS and United States of America.The strong sales and distribution network, processes and system, logistic channels, partnership with other innovators, efficient field force and the brands will help us to take the benefit of modern medicine to larger population of our country and leverage the Indian opportunity. We continue to invest in market and our people in coming years. With an increased thrust on science & training and highest ethical standards, we are determined to accelerate our performance and take our products to more doctors & patients..The leadership role comes with the sense of responsibility. Axigen, is built on core values that center our work and help focus what we do and the decision we make. We have a culture of high performance and sustain this culture through our best-in-class rewards & recognition program and a great place to work for our people.Our key focus areas lie in the prescription drugs that have wide-ranging applications across fields like Gynaecology, Infertility Management, Science-based Nutritional Health, Dermatology, Gastroenterology, Pain Management and Acute care..We have established world-class manufacturing partners by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliances. Plants are WHO, cGMP, GLP, ISO 9001, ISO 22000, HACCP, PPB Kenya, NDA Uganda certified. Manufacturing facilities have at multiple locations in India like Haryana, Dehradun, Ahmedabad and Haridwar.We are planning gradually building a meaningful presence in the Russia & CIS and US market, with select product portfolio, which include complex technology products to get the competitive advantage in the market place. We expect US market to be our key growth driver in the coming years. It also has its marketing plan in emerging markets of African Countries: Zimbabwe, Kenya, Uganda, Nigeria and French West Africa; Asian Countries: Sri Lanka, Vietnam, Myanmar, Philippines, Malaysia, Nepal and Bangladesh; MENA (Middle East Region). Doctors are continuing to remain our driving force, while we strive to support doctors in the mission to build a healthy India.

M.S.Rana

Director